Flower


Lupin and Lilly partner to improve access to diabetes treatment

by The Welthi Bureau |

lupin and lilly partner to improve access to diabetes treatment
 Image used for representational purpose only

Mumbai, October 1, 2018: Pharma Major Lupin Limited ("Lupin") and Eli Lilly and Company (India) Pvt. Ltd. ("Lilly India"), have announced the expansion of their business partnership aimed at widening access to innovative diabetes medicines in India. Under the new partnership, Lupin will distribute and market Lilly's Aplevant® (dulaglutide), a once-weekly injection for type 2 diabetes treatment.

 

Aplevant® (dulaglutide) is a once-weekly injectable solution for adults with type 2 diabetes mellitus. Lupin expects to make Aplevant® available in India in October 2018.

 

This announcement builds on the Lupin and Lilly India business partnership initiated in 2011 to expand the promotion and distribution of Lilly's diabetes portfolio in India where Lupin has a large network.

 

Rajeev Sibal, President – India Region Formulations, Lupin said, "Our long-standing partnership with Lilly has enabled us to emerge as a strong contender in the diabetes treatment arena. Lupin is the fastest growing company in the Indian diabetes market and is now ranked as the third largest company in the Anti-diabetes market in India on a MATbasis as of August 2018*. With this new partnership, we are expanding our diabetes portfolio to include a once-weekly diabetes treatment, and improving access to innovative medications for better diabetic care in India. We are delighted to partner with Lilly India and hope to continue building our product pipeline through strategic tie-ups for innovative healthcare solutions for patients and healthcare practitioners in India."

 

Luca Visini, Managing Director, Lilly India said, "Lilly's heritage in diabetes spans from the first commercial release of insulin in 1923 to leading scientific discoveries of today. Since 1923, we have continuously strived to innovate to meet the diverse needs of people living with diabetes offering a wide portfolio of treatments among which include the first biosynthetic 'human' insulin with recombinant DNA technology, the first rapid insulin analog, and a once weekly non-insulin injection for type 2 diabetes. Building on this strong heritage and legacy in the diabetes field, and our commitment to making life better for all those living with diabetes in India, we are thrilled to work with Lupin to make our innovative therapies and solutions available to a large number of healthcare professionals and patients who need them."


 Disclaimer: Welthi.com does not guarantee any specific results as a result of the procedures mentioned here, and the results may vary from person to person. Read more
Free Education to Students Who Lost Their Parents to Covid 19 AT MALLA REDDY UNIVERSITY

Free Education to Students Who Lost Their ...

Free Education to Students Who Lost Their Parents ...
Kamineni Fertility launches a state of the art  Fertility Centre at Kokapet

Kamineni Fertility launches a state of the art ...

Kamineni Fertility launches a state of the art Fe...
L V Prasad Eye Institute is part of first  Global Research Program Devoted to  Vision and Sustainable Development Goals

L V Prasad Eye Institute is part of first ...

L V Prasad Eye Institute is part of first Global ...
American patient gets treated for laryngeal cancer at Indur Cancer Hospital, Nizamabad

American patient gets treated for laryngeal ...

American patient gets treated for laryngeal cancer...
MaxiVision Eye Hospitals launches Mucormycosis (Black Fungus) Early Detection Center

MaxiVision Eye Hospitals launches Mucormycosis (...

MaxiVision Eye Hospitals launches Mucormycosis (Bl...
THINGS TO REMEMBER BEFORE, DURING AND AFTER RECEIVING COVID 19 VACCINE

THINGS TO REMEMBER BEFORE, DURING AND AFTER ...

THINGS TO REMEMBER BEFORE, DURING AND AFTER RECEIV...
Wockhardt Hospital, Mira Road conducts free general health check-up for cops

Wockhardt Hospital, Mira Road conducts free ...

Wockhardt Hospital, Mira Road conducts free genera...
SuVitas Launches Bangalore’s First Dedicated Transition Care Facility

SuVitas Launches Bangalore’s First Dedicated ...

Catering to a need for post critical care that has...
Itermittent Fasting: The How s and Why's

Itermittent Fasting: The How s and Why's

Intermittent Fasting is the latest global fitness ...
Eyes show you the world

Eyes show you the world

With increasing rate of air pollution, the ways it...
Healthcare receives major limelight in General Budget 2018-19

Healthcare receives major limelight in General ...

Healthcare has been a core segment in every develo...